FABP3 and Insulin resistance: Moreover, Shearer et al. established that reductions in plasma H-FABP may contribute to the correction of insulin resistance and glucose uptake in the heart (80), which underscores the necessity for further research into the relationship between H-FABP and DCM severity to enhance our understanding of its diagnostic role in early-stage DCM patients.